查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750868

藥物篩檢市場規模、佔有率、趨勢分析報告（按產品類型、樣品類型、最終用途、地區、細分市場預測），2025 年至 2030 年

Drug Screening Market Size, Share & Trends Analysis Report By Product Type (Instruments, Consumables), By Sample Type (Urine Sample, Breath Sample), By End-use (Drug Treatment Centers), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

藥物篩檢市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球藥物篩檢市場規模預計到2030年將達到119.9億美元，預計2025年至2030年期間的複合年成長率為4.1%。

推動這一市場發展的因素包括人們對職場安全、法規遵從性以及檢測方法技術進步推動的對藥物濫用的準確檢測要求日益成長的擔憂。

英國接受藥物和酒精服務機構治療的成年人數量增加了4.8%，從2020-2021年的275,896人增加到2021-2022年的289,215人，這表明該國藥物濫用的流行程度正在加劇。藥物濫用的日益普遍進一步表明，有必要製定有效的預防和治療策略，包括擴大循證治療方案的可及性，並開展公共衛生宣傳活動，以提高公眾對藥物和酒精濫用風險的認知。

此外，2020年12歲以上美國非法藥物使用率約為3,731萬，與過去與前一年同期比較相比成長了3.8%。這一成長凸顯了在職場、學校和醫療保健機構中開展全面藥物篩檢計畫的迫切需求，以確保安全、合規，並為那些正在與藥物濫用作鬥爭的人提供適當的護理和支持。

此外，新產品發布、併購等市場參與者的舉措也促進了市場成長。例如，2024年2月，紐約領先的藥物檢測提供者Mobile Health為雇主推出了快速藥物檢測服務，可在一小時內獲得結果。這項創新專注於尿液檢測，以其準確性和多功能性而聞名，它改進了招聘流程，並徹底改變了紐約的人才招募方式。此外，2023年12月，AvertD測試獲得美國食品藥物管理局（FDA）核准，該測試透過基因標記評估個體患有鴉片類藥物使用障礙的風險，使其成為應對鴉片類藥物危機的關鍵創新。該測試由AutoGenomics公司開發，旨在用於患者首次接觸口服鴉片類止痛藥之前，尤其適用於那些計劃接受手術的患者。該測試旨在幫助患者和醫療保健提供者就鴉片類藥物的使用做出明智的決定，從而潛在地降低成癮和濫用的風險。

藥物篩檢市場報告重點

  • 由於耗材在快速、準確和現場檢測中發揮重要作用，預計到2024年，其收入佔有率將達到34.5%。此外，頻繁的產品發布以及職場和醫療保健環境中對高效物質檢測的需求也在推動這一細分市場的成長。
  • 由於對專業藥物篩檢服務（例如實驗室分析和法規遵從支援）的需求不斷成長，預計預測期內其他服務的複合年成長率為 4.1%。
  • 尿液樣本將佔據市場主導地位，到 2024 年將佔據 41.3% 的最大收益佔有率，這主要是因為其非侵入性、簡單且方便的收集過程，使其適用於職場和臨床環境。
  • 由於易於收集、隱私問題較少以及樣本污染風險低，預計預測期內口腔液樣本將以顯著的複合年成長率成長。
  • 藥物治療將引領市場，佔據 2024 年最大的收益佔有率。預計從 2025 年到 2030 年，醫院的複合年成長率最快，為 5.2%。
  • 受藥物濫用率上升、職場安全法規嚴格以及政府措施不斷增多的推動，北美將在 2024 年佔據全球藥物篩檢市場的最大收益佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章全球藥物篩檢市場變數、趨勢與範圍

  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球藥物篩檢市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析

第4章全球藥物篩檢市場：產品類型商業分析

  • 產品類型細分儀表板
  • 藥物篩檢市場：產品類型變化分析
  • 2018-2030年全球藥物篩檢市場規模及趨勢分析（依產品類型）
  • 裝置
  • 快速檢測裝置
  • 耗材
  • 服務及更多

第5章全球藥物篩檢市場：樣本類型商業分析

  • 樣本類型細分儀表板
  • 藥物篩檢市場：樣本類型變異分析
  • 2018-2030年全球藥物篩檢市場規模及趨勢分析（依樣本類型）
  • 尿液樣本
  • 呼氣樣本
  • 口腔液體樣本
  • 頭髮樣本
  • 其他樣品

6. 全球藥物篩檢市場：最終用途業務分析

  • 最終用途細分儀表板
  • 藥物篩檢市場：最終用途變異分析
  • 2018-2030年全球藥物篩檢市場規模及趨勢分析（依最終用途）
  • 醫院
  • 刑事司法和執法
  • 職場
  • 藥物治療中心
  • 個人用戶
  • 疼痛管理中心
  • 學校和大學
  • 其他

7. 全球藥物篩檢市場：區域估計與趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 全球藥物篩檢市場（按地區）: 關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
  • 公司簡介
    • Abbott
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare AG
    • Laboratory Corporation of America Holdings
    • Alfa Scientific Designs, Inc.
    • OraSure Technologies, Inc.
    • Omega Laboratories, Inc.
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-303-9

Drug Screening Market Growth & Trends:

The global drug screening market size is estimated to reach USD 11.99 billion by 2030 and is anticipated to expand at a CAGR of 4.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and the requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.

The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.

Furthermore, the incidence of illegal substance uses amongst Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.

Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, launched rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring procedure, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.

Drug Screening Market Report Highlights:

  • Consumables held the largest revenue share of 34.5% in 2024, attributed to their essential role in rapid, accurate, and on-site testing. Furthermore, frequent product launches and the need for efficient substance detection across workplaces and healthcare settings also fuel this segment's growth
  • Services and others are expected to grow at a CAGR of 4.1% over the forecast period, owing to the increasing need for specialized drug screening services, including laboratory analysis and support for compliance with regulatory standards.
  • Urine samples dominated the market with the largest revenue share of 41.3% in 2024, primarily driven by their noninvasive, simple, and convenient collection process, which makes them suitable for both workplace and clinical settings.
  • Oral fluid samples are expected to grow at a significant CAGR over the forecast period, driven by their ease of collection, minimal privacy concerns, and lower risk of sample adulteration.
  • In 2024, drug treatment led the market and accounted for the largest revenue share. Hospitals are expected to grow at the fastest CAGR of 5.2% from 2025 to 2030.
  • North America dominated the global drug screening market with the largest revenue share in 2024, driven by rising substance abuse rates, stringent workplace safety regulations, and increasing government initiatives aimed at controlling drug-related issues.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Sample Type
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Type Outlook
    • 2.2.2. Sample Type Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Drug Screening Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Drug Screening Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Drug Screening Market: Product Type Business Analysis

  • 4.1. Product Type Segment Dashboard
  • 4.2. Drug Screening Market: Product Type Movement Analysis
  • 4.3. Global Drug Screening Market Size & Trend Analysis, By Product Type, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Immunoassays Analyzers
      • 4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Chromatography Instruments
      • 4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Breath Analyzer
      • 4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.4.4.2. Fuel Cell Breath Analyzer
        • 4.4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.4.4.3. Semi-Conductor Breath Analyzer
        • 4.4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.4.4.4. Others Breath Analyzer
        • 4.4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Rapid Testing Devices
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Urine Testing Devices
      • 4.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Drug Testing Cups
        • 4.5.2.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. Dip Cards
        • 4.5.2.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Drug Testing Cassettes
        • 4.5.2.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Oral Fluid Testing Devices
    • 4.5.4. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Assay Kits
      • 4.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Sample Collection Devices
      • 4.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Calibrators & Controls
      • 4.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Other Consumables
      • 4.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. Services & Others
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Drug Screening Market: Sample Type Business Analysis

  • 5.1. Sample Type Segment Dashboard
  • 5.2. Drug Screening Market: Sample Type Movement Analysis
  • 5.3. Global Drug Screening Market Size & Trend Analysis, By Sample Type, 2018 to 2030 (USD Million)
  • 5.4. Urine Samples
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Breath Samples
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Oral Fluid Samples
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Hair Samples
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.8. Other Samples
    • 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Drug Screening Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Drug Screening Market: End Use Movement Analysis
  • 6.3. Global Drug Screening Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. Criminal Justice & Law Enforcement Agencies
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. Workplaces
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.7. Drug Treatment Centers
    • 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.8. Individual Users
    • 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.9. Pain Management Centers
    • 6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.10. Schools & Colleges
    • 6.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Drug Screening Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Drug Screening Market by Regional: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Quest Diagnostics Incorporated
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. F. Hoffmann-La Roche Ltd
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Thermo Fisher Scientific Inc.
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Siemens Healthcare AG
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Laboratory Corporation of America Holdings
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Alfa Scientific Designs, Inc.
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. OraSure Technologies, Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Omega Laboratories, Inc.
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Dragerwerk AG & Co. KGaA
      • 8.4.10.1. Company Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. Bio-Rad Laboratories, Inc.
      • 8.4.11.1. Company Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1. List Of Abbreviations
  • Table 2. Global Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 3. Global Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 4. Global Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5. Global Drug Screening Market, By Region, 2018 - 2030 (USD Million)
  • Table 6. North America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 7. North America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 8. North America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 9. North America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10. U.S. Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 11. U.S. Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 12. U.S. Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13. Canada Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 14. Canada Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 15. Canada Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16. Mexico Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 17. Mexico Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 18. Mexico Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19. Europe Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 20. Europe Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 21. Europe Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 22. Europe Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23. Germany Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 24. Germany Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 25. Germany Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26. UK Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 27. UK Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 28. UK Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29. France Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 30. France Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 31. France Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32. Italy Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 33. Italy Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 34. Italy Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35. Spain Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 36. Spain Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 37. Spain Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38. Denmark Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 39. Denmark Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 40. Denmark Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41. Sweden Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 42. Sweden Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 43. Sweden Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44. Norway Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 45. Norway Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 46. Norway Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51. China Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 52. China Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 53. China Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54. Japan Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 55. Japan Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 56. Japan Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57. India Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 58. India Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 59. India Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60. South Korea Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 61. South Korea Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 62. South Korea Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63. Australia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 64. Australia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 65. Australia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66. Thailand Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 67. Thailand Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 68. Thailand Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69. Latin America Drug Screening Market, By Country, 2018 - 2030 (USD Million)
  • Table 70. Latin America Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 71. Latin America Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 72. Latin America Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73. Brazil Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 74. Brazil Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 75. Argentina Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 76. Argentina Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 77. Argentina Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78. MEA Drug Screening Market, By Region, 2018 - 2030 (USD Million)
  • Table 79. MEA Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 80. MEA Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 81. MEA Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82. South Africa Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 83. South Africa Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 84. South Africa Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85. Saudi Arabia Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88. UAE Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 89. UAE Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 90. UAE Drug Screening Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91. Kuwait Drug Screening Market, By Product Type, 2018 - 2030 (USD Million)
  • Table 92. Kuwait Drug Screening Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 93. Kuwait Drug Screening Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Sample Types
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Drug Screening Market: Market Outlook
  • Fig. 10 Drug Screening Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Drug Screening Market Driver Impact
  • Fig. 16 Drug Screening Market Restraint Impact
  • Fig. 17 Drug Screening Market Strategic Initiatives Analysis
  • Fig. 18 Drug Screening Market: Product Type Movement Analysis
  • Fig. 19 Drug Screening Market: Product Type Outlook and Key Takeaways
  • Fig. 20 Instruments Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Rapid Testing Devices Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Consumables Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 Services & Others Market Estimates and Forecast, 2018 - 2030
  • Fig. 24 Drug Screening Market: Sample Type Movement Analysis
  • Fig. 25 Drug Screening Market: Sample Type Outlook and Key Takeaways
  • Fig. 26 Urine Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Breath Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Oral Fluid Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Hair Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 Other Samples Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 Drug Screening Market: End Use Movement Analysis
  • Fig. 32 Drug Screening Market: End Use Outlook and Key Takeaways
  • Fig. 33 Hospitals Market Estimates and Forecasts, 2018 - 2030
  • Fig. 34 Criminal Justice & Law Enforcement Agencies Market Estimates and Forecasts, 2018 - 2030
  • Fig. 35 Workplaces Market Estimates and Forecasts, 2018 - 2030
  • Fig. 36 Drug Treatment Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Individual Users Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Pain Management Centers Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Schools & Colleges Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 41 Global Drug Screening Market: Regional Movement Analysis
  • Fig. 42 Global Drug Screening Market: Regional Outlook and Key Takeaways
  • Fig. 43 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 46 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 47 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Kuwait Market Estimates and Forecasts, 2018 - 2030